Orion Portfolio Solutions LLC Has $624,000 Position in Masimo Co. (NASDAQ:MASI)

Orion Portfolio Solutions LLC reduced its holdings in Masimo Co. (NASDAQ:MASI) by 10.3% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 4,681 shares of the medical equipment provider’s stock after selling 540 shares during the quarter. Orion Portfolio Solutions LLC’s holdings in Masimo were worth $624,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently made changes to their positions in MASI. Fifth Third Bancorp grew its position in shares of Masimo by 16.4% in the second quarter. Fifth Third Bancorp now owns 695 shares of the medical equipment provider’s stock valued at $88,000 after purchasing an additional 98 shares during the last quarter. Raymond James Trust N.A. increased its stake in Masimo by 14.3% during the second quarter. Raymond James Trust N.A. now owns 6,414 shares of the medical equipment provider’s stock valued at $808,000 after acquiring an additional 800 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in Masimo by 8.4% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 7,877 shares of the medical equipment provider’s stock valued at $992,000 after acquiring an additional 610 shares during the period. Versor Investments LP bought a new position in Masimo during the second quarter valued at about $665,000. Finally, Roubaix Capital LLC bought a new position in Masimo during the second quarter valued at about $3,128,000. 85.96% of the stock is owned by institutional investors and hedge funds.

Masimo Stock Down 1.8 %

NASDAQ:MASI opened at $174.07 on Wednesday. The stock’s fifty day moving average price is $158.09 and its two-hundred day moving average price is $133.59. Masimo Co. has a 52-week low of $101.61 and a 52-week high of $180.97. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.11 and a current ratio of 2.01. The company has a market cap of $9.32 billion, a price-to-earnings ratio of 121.37 and a beta of 1.01.

Masimo (NASDAQ:MASI) last posted its quarterly earnings data on Tuesday, November 5th. The medical equipment provider reported $0.98 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.84 by $0.14. Masimo had a return on equity of 14.98% and a net margin of 3.85%. The firm had revenue of $504.60 million for the quarter, compared to the consensus estimate of $502.87 million. During the same quarter in the prior year, the business earned $0.63 EPS. The business’s revenue for the quarter was up 5.4% compared to the same quarter last year. On average, analysts anticipate that Masimo Co. will post 4.03 EPS for the current year.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on MASI. BTIG Research boosted their price target on Masimo from $166.00 to $170.00 and gave the company a “buy” rating in a research note on Monday, October 14th. Needham & Company LLC restated a “hold” rating on shares of Masimo in a research note on Wednesday, November 6th. Stifel Nicolaus restated a “buy” rating and set a $190.00 price target (up from $170.00) on shares of Masimo in a research note on Friday, November 22nd. Piper Sandler boosted their price target on Masimo from $165.00 to $180.00 and gave the company an “overweight” rating in a research note on Wednesday, November 6th. Finally, Wells Fargo & Company upped their price objective on Masimo from $171.00 to $193.00 and gave the company an “overweight” rating in a research note on Wednesday, December 11th. Three analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $170.67.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.